Cargando…

Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer

Immunotherapy in colorectal cancer (CRC) has made great strides within the past decade. Immune checkpoint inhibitors are a class of immunotherapy and have been shown to greatly improve patient outcomes in mismatch repair-deficient (dMMR) CRC. Now, they are part of the standard of care for this subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Irene, Dakwar, Anthony, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856401/
https://www.ncbi.nlm.nih.gov/pubmed/36672193
http://dx.doi.org/10.3390/cells12020258

Ejemplares similares